| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/30/2001 | WO2001025248A3 Design of high affinity rnase h recruiting oligonucleotide |
| 08/30/2001 | WO2001024937A3 Separation apparatus and method |
| 08/30/2001 | WO2001023568A3 Members of the iap gene family |
| 08/30/2001 | WO2001016335A3 Stromelysin-homologous novel mmp-27 matrix metalloproteinase |
| 08/30/2001 | WO2001014519A3 Methods and compositions for regulating developmental identity |
| 08/30/2001 | WO2001012833A3 Process for the biological production of 1,3-propanediol |
| 08/30/2001 | WO2001012806A3 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 08/30/2001 | WO2001012801A3 Defense-related signaling genes and methods of use |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001011333A3 Apparatus for real-time measurement of cellular response |
| 08/30/2001 | WO2001011083A3 Methods for detecting mutations using primer extension |
| 08/30/2001 | WO2001011039A3 New sequence variants of the human 1-adrenoreceptor gene and use thereof |
| 08/30/2001 | WO2001009350A3 Genetically engineered bleb vaccine |
| 08/30/2001 | WO2001009325A3 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/30/2001 | WO2001009187A3 Human monoclonal antibodies to her2/neu |
| 08/30/2001 | WO2001009174A3 Plant defensin variants |
| 08/30/2001 | WO2001008702A3 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 08/30/2001 | WO2001007601A3 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 08/30/2001 | WO2001004358A3 Detection of anti-hepatitis b drug resistance |
| 08/30/2001 | WO2001004323A3 11-arachidonate-lipoxygenase mutants |
| 08/30/2001 | WO2001002568A3 Human genes and gene expression products |
| 08/30/2001 | WO2001002540A3 Adenoviral vectors for treating disease |
| 08/30/2001 | WO2000078965A3 Plant auxin proteins |
| 08/30/2001 | WO2000077250A3 Method for circularizing oligonucleotides around a double stranded nucleic acid, resulting structures and uses thereof |
| 08/30/2001 | WO2000071729A3 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 08/30/2001 | WO2000066750A3 Methods for producing plants with elevated oleic acid content |
| 08/30/2001 | WO2000047738A9 Human and mouse trek-1 potassium channel protein and their use |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | US20010018773 Production of cotton fiber with improved fiber characteristics |
| 08/30/2001 | US20010018642 Method and system for providing a probe array chip design database |
| 08/30/2001 | US20010018514 Nucleic acid labeling compounds |
| 08/30/2001 | US20010018513 Isolation of nucleic acids |
| 08/30/2001 | US20010018512 For biopolymer |
| 08/30/2001 | US20010018511 Anticancer agent |
| 08/30/2001 | US20010018427 Anticholesterol agent |
| 08/30/2001 | US20010018426 Lithium chloride |
| 08/30/2001 | US20010018414 Modified vitamin K-dependent polypeptides |
| 08/30/2001 | US20010018412 Primers specific to the target DNA fragment are immobilized on inner surfaces of the holes of a holder in a vessel; free primer common to the target DNA fragment species is mobile in the vessel with a solution and other reagents |
| 08/30/2001 | US20010018214 Culturing retrovirally infected eukaryotic cells in aseptic, low oxygen conditions; bacteria produced contain eukaryotic and viral genes |
| 08/30/2001 | US20010018211 Mutation suppresses apoptosis, permits cell proliferation; peptides including domain and nucleotides encoding domain useful for screening tumors for proliferative mutations |
| 08/30/2001 | US20010018207 Dna regulatory element for the expression of transgenes in neurons of the mouse forebrain |
| 08/30/2001 | US20010018203 DNA construction: promoter, recombinase recogniton sequence, drug resistance gene, polyA addition signal, recombinase recognition signal, virus structural protein gene, polyA addition signal, in that order |
| 08/30/2001 | US20010018202 Lentiviral vectors derived from SIVagm, methods for their preparation and their use for gene transfer into mammalian cells |
| 08/30/2001 | US20010018200 Genetic engineering; using a glycosylated thiosulfonate |
| 08/30/2001 | US20010018199 Process for preparing a desired protein |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | US20010018191 Immunology complex with epitopes; Alzheimer's disease |
| 08/30/2001 | US20010018186 Method for molecular diagnosis of tumor angiogenesis and metastasis |
| 08/30/2001 | US20010018184 Heterogenous assay for pyrophosphate |
| 08/30/2001 | US20010018183 Multicolor caomparative hybrid analysis |
| 08/30/2001 | US20010018182 Methods of monitoring disease states and therapies using gene expression profiles |
| 08/30/2001 | US20010018055 Safe, effectives vaccines for cattle, sheep and goats |
| 08/30/2001 | DE10009002A1 A new homogentisatephytyltransferase protein encoded by the open reading frame slr1376 from Synechocystis species. PCC6803 is useful to provide transgenic plants producing vitamin E |
| 08/30/2001 | DE10006204A1 Ozon- und/oder Pathogen-induzierbare Genexpression in Pflanzen Ozone and / or pathogen-inducible gene expression in plants |
| 08/30/2001 | CA2683009A1 Use of il-18 inhibitors |
| 08/30/2001 | CA2418496A1 Secretory polypeptides and corresponding polynucleotides |
| 08/30/2001 | CA2402398A1 Process for producing avermectin derivative |
| 08/30/2001 | CA2401868A1 Molecules for diagnostics and therapeutics |
| 08/30/2001 | CA2401632A1 Method for ligating nucleic acids and molecular cloning |
| 08/30/2001 | CA2401623A1 Methods and compositions for identifying a protease |
| 08/30/2001 | CA2401367A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 08/30/2001 | CA2401281A1 A process for generating cytoplasmic male sterile line in rice and other crops by rna editing |
| 08/30/2001 | CA2401256A1 A process for constructing dna based molecular marker for enabling selection of drought and diseases resistant germplasm screening |
| 08/30/2001 | CA2401247A1 A process for generating genetically modified pearl millet through agrobacterium and biolistic transformation |
| 08/30/2001 | CA2401233A1 Method for detecting cytosine methylation in dna samples |
| 08/30/2001 | CA2401219A1 Vertebrate globin |
| 08/30/2001 | CA2401198A1 Ligase/polymerase method for detecting cytosine methylation in dna samples |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401096A1 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | CA2401076A1 Molecules for disease detection and treatment |
| 08/30/2001 | CA2401070A1 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | CA2401031A1 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | CA2401018A1 Platform for the discovery of the bacterial genes involved in rna modification |
| 08/30/2001 | CA2400948A1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| 08/30/2001 | CA2400915A1 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | CA2400890A1 Method and system for the assembly of a whole genome using a shot-gun data set |
| 08/30/2001 | CA2400876A1 Novel protein and gene encoding the protein |
| 08/30/2001 | CA2400874A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | CA2400863A1 Staphylococcal gtpase obg nucleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400838A1 Novel method for down-regulation of amyloid |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400789A1 Microarray fabrication techniques and apparatus |
| 08/30/2001 | CA2400783A1 Homogentisate phytyl transferase |
| 08/30/2001 | CA2400710A1 Starch branching enzyme |
| 08/30/2001 | CA2400661A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | CA2400642A1 Modified fluorescent proteins |
| 08/30/2001 | CA2400636A1 Hybrid cell vaccines |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400544A1 Method of modulating glycosylation pathways |
| 08/30/2001 | CA2400443A1 103p2d6: tissue specific protein highly expressed in various cancers |
| 08/30/2001 | CA2400441A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | CA2400292A1 Production of mammals which produce progeny of a single sex |
| 08/30/2001 | CA2400088A1 Differential expression screening method |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/30/2001 | CA2399999A1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | CA2399550A1 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/30/2001 | CA2399298A1 Use of il-18 inhibitors |